50th Anniversary of the First Successful Permanent Pacemaker Implantation in the United States: Historical Review and Future Directions

被引:65
作者
Beck, Hiroko [2 ]
Boden, William E. [2 ,3 ]
Patibandla, Sushmitha [2 ]
Kireyev, Dmitriy [2 ]
Gupta, Vipul [2 ]
Campagna, Franklin [2 ]
Cain, Michael E. [2 ]
Marine, Joseph E. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA
[2] SUNY Buffalo, Sch Med & Biomed Sci, Buffalo, NY 14260 USA
[3] SUNY Buffalo, Sch Publ Hlth, Buffalo, NY 14260 USA
关键词
CARDIAC-RESYNCHRONIZATION THERAPY; CLOSED-LOOP STIMULATION; CLINICAL-EXPERIENCE; HEART-FAILURE; SAFETY; DEFIBRILLATOR; PERFORMANCE; PREVENTION; PATIENT; SYSTEM;
D O I
10.1016/j.amjcard.2010.04.043
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
June 2010 marks the 50th anniversary of the first successful human cardiac pacemaker implantation in the United States. On June 6, 1960, in Buffalo, New York, Dr. William Chardack implanted a pacemaker, designed and built by Wilson Greatbatch, an electrical engineer and inventor, in a 77-year old man with complete atrioventricular block, extending the patient's life by 18 months. This landmark event ushered in a new era of implantable cardiac pacemakers with batteries and leads of high reliability and increasing durability. Over the past half century, the field of electrophysiology and implantable devices for the management of cardiac conduction disturbances has evolved dramatically. Today's pacemakers include increasingly complex features such as telemetry monitoring, autoprogrammability, and hemodynamic sensors. New-generation leads present a sophisticated design with improved geometry and steroid-eluting tips to reduce chronic inflammation, maintaining a low pacing threshold and high sensing capability. The lithium iodide battery remains the mainstay of implantable pacemaker systems, exhibiting a multiple-year lifespan, slow terminal decay, and a reduced, size and cost of production. Although Great-batch's first successful pacemaker implantation remains a seminal scientific contribution to modern cardiovascular disease management, emerging developments in this field may challenge its preeminence. Important challenges such as imaging compatibility, lead durability, and infection prevention are being addressed. Novel concepts such as leadless and biologic pacing are under active investigation. In conclusion, Greatbatch's historic achievement 50 years ago reminds us that technologic progress is timeless, as efforts to enhance clinical outcomes and the quality of life continue unimpeded into the 21st century. (C) 2010 Published by Elsevier Inc. All rights reserved. (Am J Cardiol 2010;106:810-818)
引用
收藏
页码:810 / 818
页数:9
相关论文
共 69 条
  • [1] Cardiac resynchronization in chronic heart failure
    Abraham, WT
    Fisher, WG
    Smith, AL
    Delurgio, DB
    Leon, AR
    Loh, E
    Kocovic, DZ
    Packer, M
    Clavell, AL
    Hayes, DL
    Ellestad, M
    Messenger, J
    Trupp, RJ
    Underwood, J
    Pickering, F
    Truex, C
    McAtee, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (24) : 1845 - 1853
  • [2] GREATBATCH,WILSON
    ADAM, JA
    [J]. IEEE SPECTRUM, 1995, 32 (03) : 56 - 61
  • [3] CONTROL OF PACEMAKER RATE BY IMPEDANCE-BASED RESPIRATORY MINUTE VENTILATION
    ALT, E
    HEINZ, M
    HIRGSTETTER, C
    EMSLANDER, HP
    DAUM, S
    BLOMER, H
    [J]. CHEST, 1987, 92 (02) : 247 - 252
  • [4] Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay
    Auricchio, A
    Stellbrink, C
    Sack, S
    Block, M
    Vogt, J
    Bakker, P
    Huth, C
    Schöndube, F
    Wolfhard, U
    Böcker, D
    Krahnefeld, O
    Kirkels, H
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (12) : 2026 - 2033
  • [5] CONTRIBUTION OF ATRIAL SYSTOLE TO CARDIAC FUNCTION AT A FIXED AND AT A VARIABLE VENTRICULAR RATE
    BENCHIMOL, A
    DUENAS, A
    LIGGETT, MS
    DIMOND, EG
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1965, 16 (01) : 11 - +
  • [6] *BIOPH TECHN, BIOTH POW SOURC
  • [7] Bonow RO, 2008, J AM COLL CARDIOL, V52, pE1, DOI [10.1016/j.hrthm.2008.04.014, 10.1016/j.jacc.2008.05.007]
  • [8] *BOST SCI, 2009, CRM PROD PERF REP 20
  • [9] Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
    Bristow, MR
    Saxon, LA
    Boehmer, J
    Krueger, S
    Kass, DA
    De Marco, T
    Carson, P
    DiCarlo, L
    DeMets, D
    White, BG
    DeVries, DW
    Feldman, AM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) : 2140 - 2150
  • [10] Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.
    Cazeau, S
    Leclercq, C
    Lavergne, T
    Walker, S
    Varma, C
    Linde, C
    Garrigue, S
    Kappenberger, L
    Haywood, GA
    Santini, M
    Bailleul, C
    Daubert, JC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (12) : 873 - 880